Assessment of Pharmacokinetics of a Single Oral Dose of VIMOVO in Healthy Adult Volunteers

• Status: Completed
• Trial end date: 2011-06-01
• Target enrollment: 0
• Participant gender: All

Summary

This is an assessment of Pharmacokinetics of a single oral dose of VIMOVO in healthy adult volunteers.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: AstraZeneca
• Treatments: Esomeprazole; Naproxen

Criteria

Inclusion Criteria:

• Healthy male and female subjects aged 18 to 55 years

• Capable of understanding and complying with the Clinical Study Protocol

• Body mass index (BMI) of 19 to 30 kg/m2 and weight of 50 to 100 kg

Exclusion Criteria:

• Previous enrollment in the present study

• Receipt of another investigational product within 4 weeks before this study or plans to participate in another study at the same time as this study

• Female subjects with a positive urine pregnancy test